Asterand Bioscience Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Asterand Bioscience Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011891
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Asterand Bioscience Inc (Asterand) is a biopharmaceutical company that offers tissue based products and contract research services. The company offers human tissue and human tissue-based research solutions to drug discovery scientists. Its products include biospecimens, human tissue and biofluids, and human tissue derived products. Asterand provides human tissue derived products such as cell lines, primary cells, and tissue microArray. The company offers services such as custom biospecimen procurement, IHC annotation, mutation analysis, target and biomarker validation, compound evaluation and safety, and companion diagnostics. It has its presence in Japan and the US. Asterand is headquartered in Detroit, Michigan, the US.

Asterand Bioscience Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Asterand Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Asterand Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Asterand Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Asterand Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Asterand Bioscience Inc, Medical Devices Deals, 2011 to YTD 2017 9
Asterand Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Asterand Bioscience Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Asterand Bioscience Enters into Contract Agreement with National Institutes of Health 11
Acquisition 12
BioreclamationIVT Acquires Asterand Bioscience 12
Asterand Bioscience Acquires AdeptBio 13
Asterand Bioscience Inc – Key Competitors 14
Asterand Bioscience Inc – Key Employees 15
Asterand Bioscience Inc – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Asterand Bioscience Inc, Pharmaceuticals & Healthcare, Key Facts 2
Asterand Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Asterand Bioscience Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Asterand Bioscience Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Asterand Bioscience Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Asterand Bioscience Inc, Medical Devices Deals, 2011 to YTD 2017 9
Asterand Bioscience Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Asterand Bioscience Enters into Contract Agreement with National Institutes of Health 11
BioreclamationIVT Acquires Asterand Bioscience 12
Asterand Bioscience Acquires AdeptBio 13
Asterand Bioscience Inc, Key Competitors 14
Asterand Bioscience Inc, Key Employees 15
Asterand Bioscience Inc, Other Locations 16
Asterand Bioscience Inc, Subsidiaries 16

★海外企業調査レポート[Asterand Bioscience Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tenaga Nasional Bhd (TENAGA):企業の財務・戦略的SWOT分析
    Tenaga Nasional Bhd (TENAGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • C&J Energy Services Inc (CJ):石油・ガス:M&Aディール及び事業提携情報
    Summary C&J Energy Services Inc (C&J) is a provider of onshore well construction, completion, support and other complementary oilfield services. The company offers vertically-integrated suite of services involved in the entire life cycle of the well, including hydraulic fracturing, cased-hole wireli …
  • China Petroleum & Chemical Corp:企業の戦略・SWOT・財務分析
    China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Cellmid Ltd (CDY):企業の財務・戦略的SWOT分析
    Summary Cellmid Ltd (Cellmid), formerly Medical Therapies Ltd, is a life sciences company that develops and commercializes diagnostic and therapeutic products. The company holds comprehensive portfolio of intellectual property relating to the novel targets midkine and FGF5. It offers products such a …
  • Liechtensteinische Landesbank AG:企業の戦略・SWOT・財務情報
    Liechtensteinische Landesbank AG - Strategy, SWOT and Corporate Finance Report Summary Liechtensteinische Landesbank AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • ChemoCentryx Inc (CCXI):企業の財務・戦略的SWOT分析
    Summary ChemoCentryx Inc (ChemoCentryx) is a bio pharmaceutical company that discovers, develops and commercializes orally-administered therapeutics for the treatment of cancer, autoimmune diseases and inflammatory disorders. The company's lead drug candidate include Avacopan, an orally-administered …
  • SAS AB:企業の戦略・SWOT・財務情報
    SAS AB - Strategy, SWOT and Corporate Finance Report Summary SAS AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • Acceleron Pharma Inc (XLRN):企業の財務・戦略的SWOT分析
    Acceleron Pharma Inc (XLRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Exicure Inc-製薬・医療分野:企業M&A・提携分析
    Summary Exicure Inc (Exicure), formerly AuraSense Therapeutics LLC, is a biotechnology company that develops and commercializes immunomodulatory and gene silencing drugs based on 3-dimensional spherical nucleic acid (SNA) constructs. Its technology portfolio includes SNA gene regulation platform and …
  • Armanino Foods of Distinction Inc.:企業の戦略・SWOT・財務情報
    Armanino Foods of Distinction Inc. - Strategy, SWOT and Corporate Finance Report Summary Armanino Foods of Distinction Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Semiconductor Manufacturing International Corporation:企業の戦略・SWOT・財務分析
    Semiconductor Manufacturing International Corporation - Strategy, SWOT and Corporate Finance Report Summary Semiconductor Manufacturing International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • Debt Resolve Inc (DRSV):企業の財務・戦略的SWOT分析
    Summary Debt Resolve Inc (Debt Resolve) is a technology company that offers cloud-based software and services. The company develops and markets patent-based web collection technologies. It provides solutions for non-payment of bills, debts, damages and other financial disputes. Debt Resolve also off …
  • CRH Medical Corp (CRH):企業の財務・戦略的SWOT分析
    Summary CRH Medical Corp (CRH Medical), is a medical device company that offers treatment of hemorrhoids. The company provides CRH O’Regan System, a hemorrhoid technology for treating hemorrhoid. It offers topical ointments and creams including preparation H for the treatment of hemorrhoid. CRH Medi …
  • Green Plains Inc.:企業の戦略・SWOT・財務情報
    Green Plains Inc. - Strategy, SWOT and Corporate Finance Report Summary Green Plains Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Corporation Bank:企業の戦略・SWOT・財務情報
    Corporation Bank - Strategy, SWOT and Corporate Finance Report Summary Corporation Bank - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Vietnam Bank for Agriculture and Rural Development:企業の戦略的SWOT分析
    Vietnam Bank for Agriculture and Rural Development - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compet …
  • Reinsurance Group of America Inc:企業の戦略・SWOT・財務分析
    Reinsurance Group of America Inc - Strategy, SWOT and Corporate Finance Report Summary Reinsurance Group of America Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Electricidade de Mocambique EP:企業の戦略的SWOT分析
    Electricidade de Mocambique EP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • AIM Health Group Inc:企業の戦略的SWOT分析
    AIM Health Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Global Telecom Holding SAE:企業の戦略的SWOT分析
    Global Telecom Holding SAE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆